Picture

Questions?

+1-866-353-3335

SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare
Free Samples
Biotechnology Equipment

PUBLISHER: Persistence Market Research | PRODUCT CODE: 1442616

Cover Image

PUBLISHER: Persistence Market Research | PRODUCT CODE: 1442616

At-Home Molecular Testing Market by Product Type, End-Users, and Geography (North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa): Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2023-2030

PUBLISHED:
PAGES: 221 Pages
DELIVERY TIME: 2-5 business days
REQUEST FREE SAMPLE
REQUEST CUSTOMIZATION
SELECT AN OPTION
Unprintable PDF (Single User License)
USD 4900
PDF (Multi User License)
USD 7600
PDF (Corporate User License)
USD 10600

Add to Cart

Description

Table of Contents

Persistence Market Research has recently conducted an in-depth analysis of the At-Home Molecular Testing Market, providing a comprehensive report on the global landscape. This report offers key insights into market dynamics, trends, opportunities, and challenges, offering a detailed overview of the market structure. The research publication presents exclusive data and statistics, projecting the anticipated growth trajectory of the At-Home Molecular Testing Market from 2023 to 2030.

The at-home molecular testing market is projected to grow steadily, with a compound annual growth rate (CAGR) of 6.0%. It is expected to rise from its 2023 value of US$10.9 billion to reach US$16.3 billion by the conclusion of 2030.

  • Key Insights:

At-home Molecular Testing Market Size (2023E): US$10.9 Bn

Projected Market Value (2030F): US$16.3 Bn

Global Market Growth Rate (CAGR 2023 to 2030): 6.0%

Historical Market Growth Rate (CAGR 2018 to 2022): 5.7%

At-Home Molecular Testing Market - Report Scope

The at-home molecular testing market is witnessing rapid expansion, offering convenient molecular diagnostic tests that individuals can perform from their homes. These tests typically involve analyzing genetic material like DNA or RNA, providing insights into various aspects of health such as familial relationships, potential risks for specific diseases, and genetic predispositions. This innovative approach to diagnostics empowers individuals to take proactive steps towards managing their health by offering accessible and convenient testing solutions. With continuous technological advancements streamlining and reducing the cost of molecular testing, the at-home molecular testing market is experiencing significant growth.

Several key factors are driving the substantial expansion of the global at-home molecular testing industry. Firstly, the increasing recognition and interest in personalized medicine have fueled demand for genetic testing services, which offer tailored analyses of individual health profiles. Consumers are increasingly seeking genetic information to make well-informed decisions about preventive measures, lifestyle choices, and potential medical interventions. Additionally, advancements in molecular biology techniques and the availability of user-friendly testing tools have simplified the process of sample collection and submission for home-based analysis. This enhanced convenience has played a pivotal role in market growth, appealing to a broader range of user demographics.

  • Market Growth Drivers

The escalating demand for personalized medication is a significant driving force behind the global market expansion of at-home molecular testing. This form of testing plays a crucial role in the evolving landscape of personalized healthcare, which has shifted towards tailoring medical interventions based on individual genetic profiles. Central to personalized medicine is the belief that healthcare should be customized to each patient's unique genetic makeup. As awareness grows about the potential benefits of understanding one's genetic predispositions, there's been a corresponding increase in the demand for at-home molecular testing. This demand is fueled by a desire for proactive health management.

In today's healthcare environment, patients seek more than reactive treatments; they want to be empowered with knowledge to proactively manage their health. Personalized medicine holds appeal because it identifies individual susceptibilities to specific diseases, empowering people to adopt preventive measures and make lifestyle adjustments based on their genetic predispositions. At-home molecular testing facilitates this proactive approach by providing individuals with a convenient and accessible means to analyze their genetic composition without needing to visit a clinical facility. Advancements in genetic research have led to the discovery of numerous genetic markers associated with a wide range of health conditions, including hereditary diseases and predispositions to lifestyle-related ailments.

  • Market Restraints

One significant challenge facing the global market for at-home molecular testing is ensuring the precision and reliability of outcomes obtained outside of clinical settings. While the accessibility and user-friendliness of at-home testing have led to its widespread adoption, the absence of expert supervision during sample collection raises concerns about potential inaccuracies and inconsistencies. Unlike traditional laboratory settings where trained professionals oversee sample collection, DIY testing introduces the risk of inadvertent variables that may compromise result accuracy. This becomes particularly critical when making diagnostic and health-related decisions based on these outcomes. To ensure the quality and reliability of testing services, navigating the regulatory landscape and adhering to stringent oversight requirements pose significant challenges for the global at-home molecular testing market.

The growing prevalence of at-home molecular testing presents regulatory bodies with the complex task of keeping pace with technological advancements while safeguarding consumer interests. The regulatory environment is further complicated by the diverse range of tests available, spanning health predisposition assessments to ancestry profiling. Striking a balance between fostering innovation and protecting consumers necessitates a nuanced approach. The challenge lies in developing comprehensive regulations that effectively govern at-home testing, addressing its unique characteristics, ensuring result accuracy, safeguarding data privacy, and minimizing potential health risks.

  • Opportunities

The rapid integration of machine learning (ML) and Artificial Intelligence (AI) technologies is propelling the global market for at-home molecular testing forward. This incorporation of advanced computational tools with molecular diagnostics holds the potential to revolutionize at-home testing, offering opportunities for enhanced efficiency, precision, and personalized insights. As the volume of genetic data generated through at-home molecular testing increases, ML and AI algorithms play a crucial role in uncovering significant patterns and correlations, transforming raw data into actionable insights.

The fusion of AI and machine learning brings about a fundamental shift in genetic data analysis, allowing for more comprehensive understanding of an individual's health profile. These technologies can detect subtle patterns and associations that traditional analytical methods may overlook, analyzing vast datasets at speeds and scales beyond human capacity. This not only enhances the accuracy of diagnostic results but also opens avenues for more advanced and personalized health recommendations. AI-powered platforms can unravel intricate genetic interactions, offering deeper insights into disease risks and potential treatment responses.

Key Questions Answered in Report::

  • What is the current size and growth rate of the global at-home molecular testing market?
  • What are the main factors driving the expansion of at-home molecular testing?
  • How does personalized medicine contribute to the growth of this market?
  • What challenges exist regarding the precision and reliability of at-home testing outcomes?
  • What regulatory hurdles and oversight requirements impact the at-home molecular testing market?

Competitive Intelligence and Business Strategy

Prominent players in the at-home molecular testing market, such as 23andMe, MyHeritage, and AncestryDNA, bolster and expand their market dominance through strategic initiatives. One crucial strategy involves diversifying testing services to meet a wide range of consumer needs. These companies offer comprehensive genetic testing products encompassing health-related insights, carrier status for specific conditions, disease susceptibilities, and ancestry research. By providing such a broad range of services, they not only attract a larger customer base but also foster customer loyalty by continually providing valuable insights. Moreover, robust branding and marketing strategies are vital for establishing and maintaining market leadership. These companies invest significantly in advertising campaigns to educate consumers about the benefits of at-home molecular testing. To make genetic testing more accessible to the general public, persuasive messaging often relies on celebrity endorsements, customer testimonials, and compelling narratives. Furthermore, strategic partnerships with pharmaceutical firms, healthcare providers, and research institutions are integral to their approach. By forming such alliances, these companies integrate their at-home molecular testing solutions into broader healthcare networks, potentially influencing medical interventions and treatment strategies informed by genetic information. This integration positions them as key players at the intersection of mainstream healthcare and genetic testing, while also expanding their market presence.

  • Key Companies Profiled
  • Abbott
  • ACON Laboratories, Inc.
  • Rapikit
  • Becton and Dickinson
  • Cardinal Health
  • B. Braun Melsungen AG
  • Piramal Enterprises Ltd.
  • Siemens Healthcare GmbH
  • Quidel Corporation
  • Bionime Corporation
  • SA Scientific
  • ARKRAY USA, Inc.
  • Nova Biomedical
  • AdvaCare Pharma
  • AccuBioTech Co., Ltd.
  • Atlas Medical UK

TaiDoc Technology Corporation

  • Dragerwerk AG & Co. KGaA
  • F. Hoffmann-La Roche Ltd
  • Sensing Self
  • PTE. Ltd
  • Atomo Diagnostics
  • Mankind Pharma

At-home Molecular Testing Market Segmentation

  • By Product:
  • Cassettes
  • Strips
  • Test Panels
  • Dip Cards
  • Midstream
  • Others
  • By Test Type:
  • Pregnancy Tests
  • HIV Tests
  • Diabetes
  • Infectious Diseases
  • Glucose Tests
  • Ovulation Predictor Tests
  • Drug Abuse Tests
  • Others
  • By Sample Type:
  • Urine
  • Blood
  • Saliva
  • Others
  • By Distribution Channel:
  • Retail Pharmacies
  • Drug Stores
  • Supermarkets/Hypermarkets
  • Online Pharmacies
  • By Region:
  • North America
  • Europe
  • East Asia
  • South Asia & Oceania
  • Latin America
  • Middle East & Africa
Show more
Product Code: PMRREP33685

Table of Contents

1. Executive Summary

  • 1.1. Global At-home Molecular Testing Market Snapshot, 2023 and 2030
  • 1.2. Market Opportunity Assessment, 2023 - 2030, US$ Mn
  • 1.3. Key Market Trends
  • 1.4. Future Market Projections
  • 1.5. Premium Market Insights
  • 1.6. Industry Developments and Key Market Events
  • 1.7. PMR Analysis and Recommendations

2. Market Overview

  • 2.1. Market Scope and Definition
  • 2.2. Market Dynamics
    • 2.2.1. Drivers
    • 2.2.2. Restraints
    • 2.2.3. Opportunity
    • 2.2.4. Challenges
    • 2.2.5. Key Trends
  • 2.3. Product Lifecycle Analysis
  • 2.4. At-home Molecular Testing Market: Value Chain
    • 2.4.1. List of Raw Material Supplier
    • 2.4.2. List of Manufacturers
    • 2.4.3. List of Distributors
    • 2.4.4. List of Applications
    • 2.4.5. Profitability Analysis
  • 2.5. Porter Five Force's Analysis
  • 2.6. Geopolitical Tensions: Market Impact
  • 2.7. Macro-Economic Factors
    • 2.7.1. Global Sectorial Outlook
    • 2.7.2. Global GDP Growth Outlook
    • 2.7.3. Global Parent Market Overview
  • 2.8. Forecast Factors - Relevance and Impact
  • 2.9. Regulatory and Technology Landscape

3. Global At-home Molecular Testing Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)

  • 3.1. Key Highlights
    • 3.1.1. Market Volume (Units) Projections
    • 3.1.2. Market Size and Y-o-Y Growth
    • 3.1.3. Absolute $ Opportunity
  • 3.2. Market Size (US$ Mn) Analysis and Forecast
    • 3.2.1. Historical Market Size Analysis, 2013-2016
    • 3.2.2. Current Market Size Forecast, 2018-2026
  • 3.3. Global At-home Molecular Testing Market Outlook: Product
    • 3.3.1. Introduction / Key Findings
    • 3.3.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Product, 2018 - 2022
    • 3.3.3. Current Market Size (US$ Mn) and Volume (Units) Forecast By Product, 2023 - 2030
      • 3.3.3.1. Cassettes
      • 3.3.3.2. Strips
      • 3.3.3.3. Test Panels
      • 3.3.3.4. Dip Cards
      • 3.3.3.5. Midstreams
      • 3.3.3.6. Others
  • 3.4. Market Attractiveness Analysis: Product
  • 3.5. Global At-home Molecular Testing Market Outlook: Test Type
    • 3.5.1. Introduction / Key Findings
    • 3.5.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Test Type, 2018 - 2022
    • 3.5.3. Current Market Size (US$ Mn) and Volume (Units) Forecast By Test Type, 2023 - 2030
      • 3.5.3.1. Pregnancy Tests
      • 3.5.3.2. HIV Tests
      • 3.5.3.3. Diabetes
      • 3.5.3.4. Infectious Diseases
      • 3.5.3.5. Glucose Tests
      • 3.5.3.6. Ovulation Predictor Tests
      • 3.5.3.7. Drug Abuse Tests
      • 3.5.3.8. Others
  • 3.6. Market Attractiveness Analysis: Test Type
  • 3.7. Global At-home Molecular Testing Market Outlook: Sample Type
    • 3.7.1. Introduction / Key Findings
    • 3.7.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Sample Type, 2018 - 2022
    • 3.7.3. Current Market Size (US$ Mn) and Volume (Units) Forecast By Sample Type, 2023 - 2030
      • 3.7.3.1. Urine
      • 3.7.3.2. Blood
      • 3.7.3.3. Saliva
      • 3.7.3.4. Others
  • 3.8. Market Attractiveness Analysis: Sample Type
  • 3.9. Global At-home Molecular Testing Market Outlook: Distribution Channel
    • 3.9.1. Introduction / Key Findings
    • 3.9.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Distribution Channel, 2018 - 2022
    • 3.9.3. Current Market Size (US$ Mn) and Volume (Units) Forecast By Distribution Channel, 2023 - 2030
      • 3.9.3.1. Retail Pharmacies
      • 3.9.3.2. Drug Stores
      • 3.9.3.3. Supermarkets/Hypermarkets
      • 3.9.3.4. Online Pharmacies
  • 3.10. Market Attractiveness Analysis: Distribution Channel

4. Global At-home Molecular Testing Market Outlook: Region

  • 4.1. Key Highlights
  • 4.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Region, 2018 - 2022
  • 4.3. Current Market Size (US$ Mn) and Volume (Units) Forecast By Region, 2023 - 2030
    • 4.3.1. North America
    • 4.3.2. Europe
    • 4.3.3. East Asia
    • 4.3.4. South Asia and Oceania
    • 4.3.5. Latin America
    • 4.3.6. Middle East & Africa (MEA)
  • 4.4. Market Attractiveness Analysis: Region

5. North America At-home Molecular Testing Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)

  • 5.1. Key Highlights
  • 5.2. Pricing Analysis
  • 5.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
    • 5.3.1. By Country
    • 5.3.2. By Product
    • 5.3.3. By Test Type
    • 5.3.4. By Sample Type
    • 5.3.5. By Distribution Channel
  • 5.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
    • 5.4.1. U.S.
    • 5.4.2. Canada
  • 5.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Product, 2023 - 2030
    • 5.5.1. Cassettes
    • 5.5.2. Strips
    • 5.5.3. Test Panels
    • 5.5.4. Dip Cards
    • 5.5.5. Midstreams
    • 5.5.6. Others
  • 5.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Test Type, 2023 - 2030
    • 5.6.1. Pregnancy Tests
    • 5.6.2. HIV Tests
    • 5.6.3. Diabetes
    • 5.6.4. Infectious Diseases
    • 5.6.5. Glucose Tests
    • 5.6.6. Ovulation Predictor Tests
    • 5.6.7. Drug Abuse Tests
    • 5.6.8. Others
  • 5.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By Sample Type, 2023 - 2030
    • 5.7.1. Urine
    • 5.7.2. Blood
    • 5.7.3. Saliva
    • 5.7.4. Others
  • 5.8. Current Market Size (US$ Mn) and Volume (Units) Forecast By Distribution Channel, 2023 - 2030
    • 5.8.1. Retail Pharmacies
    • 5.8.2. Drug Stores
    • 5.8.3. Supermarkets/Hypermarkets
    • 5.8.4. Online Pharmacies
  • 5.9. Market Attractiveness Analysis

6. Europe At-home Molecular Testing Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)

  • 6.1. Key Highlights
  • 6.2. Pricing Analysis
  • 6.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
    • 6.3.1. By Country
    • 6.3.2. By Product
    • 6.3.3. By Test Type
    • 6.3.4. By Sample Type
    • 6.3.5. By Distribution Channel
  • 6.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
    • 6.4.1. Germany
    • 6.4.2. France
    • 6.4.3. U.K.
    • 6.4.4. Italy
    • 6.4.5. Spain
    • 6.4.6. Russia
    • 6.4.7. Turkiye
    • 6.4.8. Rest of Europe
  • 6.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Product, 2023 - 2030
    • 6.5.1. Cassettes
    • 6.5.2. Strips
    • 6.5.3. Test Panels
    • 6.5.4. Dip Cards
    • 6.5.5. Midstreams
    • 6.5.6. Others
  • 6.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Test Type, 2023 - 2030
    • 6.6.1. Pregnancy Tests
    • 6.6.2. HIV Tests
    • 6.6.3. Diabetes
    • 6.6.4. Infectious Diseases
    • 6.6.5. Glucose Tests
    • 6.6.6. Ovulation Predictor Tests
    • 6.6.7. Drug Abuse Tests
    • 6.6.8. Others
  • 6.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By Sample Type, 2023 - 2030
    • 6.7.1. Urine
    • 6.7.2. Blood
    • 6.7.3. Saliva
    • 6.7.4. Others
  • 6.8. Current Market Size (US$ Mn) and Volume (Units) Forecast By Distribution Channel, 2023 - 2030
    • 6.8.1. Retail Pharmacies
    • 6.8.2. Drug Stores
    • 6.8.3. Supermarkets/Hypermarkets
    • 6.8.4. Online Pharmacies
  • 6.9. Market Attractiveness Analysis

7. East Asia At-home Molecular Testing Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)

  • 7.1. Key Highlights
  • 7.2. Pricing Analysis
  • 7.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
    • 7.3.1. By Country
    • 7.3.2. By Product
    • 7.3.3. By Test Type
    • 7.3.4. By Sample Type
    • 7.3.5. By Distribution Channel
  • 7.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
    • 7.4.1. China
    • 7.4.2. Japan
    • 7.4.3. South Korea
  • 7.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Product, 2023 - 2030
    • 7.5.1. Cassettes
    • 7.5.2. Strips
    • 7.5.3. Test Panels
    • 7.5.4. Dip Cards
    • 7.5.5. Midstreams
    • 7.5.6. Others
  • 7.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Test Type, 2023 - 2030
    • 7.6.1. Pregnancy Tests
    • 7.6.2. HIV Tests
    • 7.6.3. Diabetes
    • 7.6.4. Infectious Diseases
    • 7.6.5. Glucose Tests
    • 7.6.6. Ovulation Predictor Tests
    • 7.6.7. Drug Abuse Tests
    • 7.6.8. Others
  • 7.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By Sample Type, 2023 - 2030
    • 7.7.1. Urine
    • 7.7.2. Blood
    • 7.7.3. Saliva
    • 7.7.4. Others
  • 7.8. Current Market Size (US$ Mn) and Volume (Units) Forecast By Distribution Channel, 2023 - 2030
    • 7.8.1. Retail Pharmacies
    • 7.8.2. Drug Stores
    • 7.8.3. Supermarkets/Hypermarkets
    • 7.8.4. Online Pharmacies
  • 7.9. Market Attractiveness Analysis

8. South Asia & Oceania At-home Molecular Testing Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)

  • 8.1. Key Highlights
  • 8.2. Pricing Analysis
  • 8.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
    • 8.3.1. By Country
    • 8.3.2. By Product
    • 8.3.3. By Test Type
    • 8.3.4. By Sample Type
    • 8.3.5. By Distribution Channel
  • 8.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
    • 8.4.1. India
    • 8.4.2. Southeast Asia
    • 8.4.3. ANZ
    • 8.4.4. Rest of South Asia & Oceania
  • 8.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Product, 2023 - 2030
    • 8.5.1. Cassettes
    • 8.5.2. Strips
    • 8.5.3. Test Panels
    • 8.5.4. Dip Cards
    • 8.5.5. Midstreams
    • 8.5.6. Others
  • 8.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Test Type, 2023 - 2030
    • 8.6.1. Pregnancy Tests
    • 8.6.2. HIV Tests
    • 8.6.3. Diabetes
    • 8.6.4. Infectious Diseases
    • 8.6.5. Glucose Tests
    • 8.6.6. Ovulation Predictor Tests
    • 8.6.7. Drug Abuse Tests
    • 8.6.8. Others
  • 8.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By Sample Type, 2023 - 2030
    • 8.7.1. Urine
    • 8.7.2. Blood
    • 8.7.3. Saliva
    • 8.7.4. Others
  • 8.8. Current Market Size (US$ Mn) and Volume (Units) Forecast By Distribution Channel, 2023 - 2030
    • 8.8.1. Retail Pharmacies
    • 8.8.2. Drug Stores
    • 8.8.3. Supermarkets/Hypermarkets
    • 8.8.4. Online Pharmacies
  • 8.9. Market Attractiveness Analysis

9. Latin America At-home Molecular Testing Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)

  • 9.1. Key Highlights
  • 9.2. Pricing Analysis
  • 9.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
    • 9.3.1. By Country
    • 9.3.2. By Product
    • 9.3.3. By Test Type
    • 9.3.4. By Sample Type
    • 9.3.5. By Distribution Channel
  • 9.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
    • 9.4.1. Brazil
    • 9.4.2. Mexico
    • 9.4.3. Rest of Latin America
  • 9.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Product, 2023 - 2030
    • 9.5.1. Cassettes
    • 9.5.2. Strips
    • 9.5.3. Test Panels
    • 9.5.4. Dip Cards
    • 9.5.5. Midstreams
    • 9.5.6. Others
  • 9.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Test Type, 2023 - 2030
    • 9.6.1. Pregnancy Tests
    • 9.6.2. HIV Tests
    • 9.6.3. Diabetes
    • 9.6.4. Infectious Diseases
    • 9.6.5. Glucose Tests
    • 9.6.6. Ovulation Predictor Tests
    • 9.6.7. Drug Abuse Tests
    • 9.6.8. Others
  • 9.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By Sample Type, 2023 - 2030
    • 9.7.1. Urine
    • 9.7.2. Blood
    • 9.7.3. Saliva
    • 9.7.4. Others
  • 9.8. Current Market Size (US$ Mn) and Volume (Units) Forecast By Distribution Channel, 2023 - 2030
    • 9.8.1. Retail Pharmacies
    • 9.8.2. Drug Stores
    • 9.8.3. Supermarkets/Hypermarkets
    • 9.8.4. Online Pharmacies
  • 9.9. Market Attractiveness Analysis

10. Middle East & Africa At-home Molecular Testing Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)

  • 10.1. Key Highlights
  • 10.2. Pricing Analysis
  • 10.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
    • 10.3.1. By Country
    • 10.3.2. By Product
    • 10.3.3. By Test Type
    • 10.3.4. By Sample Type
    • 10.3.5. By Distribution Channel
  • 10.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
    • 10.4.1. GCC
    • 10.4.2. Egypt
    • 10.4.3. South Africa
    • 10.4.4. Northern Africa
    • 10.4.5. Rest of Middle East & Africa
  • 10.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Product, 2023 - 2030
    • 10.5.1. Cassettes
    • 10.5.2. Strips
    • 10.5.3. Test Panels
    • 10.5.4. Dip Cards
    • 10.5.5. Midstreams
    • 10.5.6. Others
  • 10.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Test Type, 2023 - 2030
    • 10.6.1. Pregnancy Tests
    • 10.6.2. HIV Tests
    • 10.6.3. Diabetes
    • 10.6.4. Infectious Diseases
    • 10.6.5. Glucose Tests
    • 10.6.6. Ovulation Predictor Tests
    • 10.6.7. Drug Abuse Tests
    • 10.6.8. Others
  • 10.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By Sample Type, 2023 - 2030
    • 10.7.1. Urine
    • 10.7.2. Blood
    • 10.7.3. Saliva
    • 10.7.4. Others
  • 10.8. Current Market Size (US$ Mn) and Volume (Units) Forecast By Distribution Channel, 2023 - 2030
    • 10.8.1. Retail Pharmacies
    • 10.8.2. Drug Stores
    • 10.8.3. Supermarkets/Hypermarkets
    • 10.8.4. Online Pharmacies
  • 10.9. Market Attractiveness Analysis

11. Competition Landscape

  • 11.1. Market Share Analysis, 2022
  • 11.2. Market Structure
    • 11.2.1. Competition Intensity Mapping By Market
    • 11.2.2. Competition Dashboard
    • 11.2.3. Apparent Product Capacity
  • 11.3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
    • 11.3.1. Abbott
      • 11.3.1.1. Overview
      • 11.3.1.2. Segments and Product
      • 11.3.1.3. Key Financials
      • 11.3.1.4. Market Developments
      • 11.3.1.5. Market Strategy
    • 11.3.2. ACON Laboratories, Inc.
      • 11.3.2.1. Overview
      • 11.3.2.2. Segments and Product
      • 11.3.2.3. Key Financials
      • 11.3.2.4. Market Developments
      • 11.3.2.5. Market Strategy
    • 11.3.3. Rapikit
      • 11.3.3.1. Overview
      • 11.3.3.2. Segments and Product
      • 11.3.3.3. Key Financials
      • 11.3.3.4. Market Developments
      • 11.3.3.5. Market Strategy
    • 11.3.4. Becton and Dickinson
      • 11.3.4.1. Overview
      • 11.3.4.2. Segments and Product
      • 11.3.4.3. Key Financials
      • 11.3.4.4. Market Developments
      • 11.3.4.5. Market Strategy
    • 11.3.5. Cardinal Health
      • 11.3.5.1. Overview
      • 11.3.5.2. Segments and Product
      • 11.3.5.3. Key Financials
      • 11.3.5.4. Market Developments
      • 11.3.5.5. Market Strategy
    • 11.3.6. B. Braun Melsungen AG
      • 11.3.6.1. Overview
      • 11.3.6.2. Segments and Product
      • 11.3.6.3. Key Financials
      • 11.3.6.4. Market Developments
      • 11.3.6.5. Market Strategy
    • 11.3.7. Piramal Enterprises Ltd.
      • 11.3.7.1. Overview
      • 11.3.7.2. Segments and Product
      • 11.3.7.3. Key Financials
      • 11.3.7.4. Market Developments
      • 11.3.7.5. Market Strategy
    • 11.3.8. Siemens Healthcare GmbH
      • 11.3.8.1. Overview
      • 11.3.8.2. Segments and Product
      • 11.3.8.3. Key Financials
      • 11.3.8.4. Market Developments
      • 11.3.8.5. Market Strategy
    • 11.3.9. Quidel Corporation
      • 11.3.9.1. Overview
      • 11.3.9.2. Segments and Product
      • 11.3.9.3. Key Financials
      • 11.3.9.4. Market Developments
      • 11.3.9.5. Market Strategy
    • 11.3.10. Bionime Corporation
      • 11.3.10.1. Overview
      • 11.3.10.2. Segments and Product
      • 11.3.10.3. Key Financials
      • 11.3.10.4. Market Developments
      • 11.3.10.5. Market Strategy
    • 11.3.11. SA Scientific
      • 11.3.11.1. Overview
      • 11.3.11.2. Segments and Product
      • 11.3.11.3. Key Financials
      • 11.3.11.4. Market Developments
      • 11.3.11.5. Market Strategy
    • 11.3.12. ARKRAY USA, Inc.
      • 11.3.12.1. Overview
      • 11.3.12.2. Segments and Product
      • 11.3.12.3. Key Financials
      • 11.3.12.4. Market Developments
      • 11.3.12.5. Market Strategy
    • 11.3.13. Nova Biomedical
      • 11.3.13.1. Overview
      • 11.3.13.2. Segments and Product
      • 11.3.13.3. Key Financials
      • 11.3.13.4. Market Developments
      • 11.3.13.5. Market Strategy
    • 11.3.14. AdvaCare Pharma
      • 11.3.14.1. Overview
      • 11.3.14.2. Segments and Product
      • 11.3.14.3. Key Financials
      • 11.3.14.4. Market Developments
      • 11.3.14.5. Market Strategy
    • 11.3.15. AccuBioTech Co., Ltd.
      • 11.3.15.1. Overview
      • 11.3.15.2. Segments and Product
      • 11.3.15.3. Key Financials
      • 11.3.15.4. Market Developments
      • 11.3.15.5. Market Strategy
    • 11.3.16. Atlas Medical UK
      • 11.3.16.1. Overview
      • 11.3.16.2. Segments and Product
      • 11.3.16.3. Key Financials
      • 11.3.16.4. Market Developments
      • 11.3.16.5. Market Strategy
    • 11.3.17. TaiDoc Technology Corporation
      • 11.3.17.1. Overview
      • 11.3.17.2. Segments and Product
      • 11.3.17.3. Key Financials
      • 11.3.17.4. Market Developments
      • 11.3.17.5. Market Strategy
    • 11.3.18. Dragerwerk AG & Co. KGaA
      • 11.3.18.1. Overview
      • 11.3.18.2. Segments and Product
      • 11.3.18.3. Key Financials
      • 11.3.18.4. Market Developments
      • 11.3.18.5. Market Strategy
    • 11.3.19. F. Hoffmann-La Roche Ltd
      • 11.3.19.1. Overview
      • 11.3.19.2. Segments and Product
      • 11.3.19.3. Key Financials
      • 11.3.19.4. Market Developments
      • 11.3.19.5. Market Strategy
    • 11.3.20. Sensing Self
      • 11.3.20.1. Overview
      • 11.3.20.2. Segments and Product
      • 11.3.20.3. Key Financials
      • 11.3.20.4. Market Developments
      • 11.3.20.5. Market Strategy
    • 11.3.21. PTE. Ltd
      • 11.3.21.1. Overview
      • 11.3.21.2. Segments and Product
      • 11.3.21.3. Key Financials
      • 11.3.21.4. Market Developments
      • 11.3.21.5. Market Strategy
    • 11.3.22. Atomo Diagnostics
      • 11.3.22.1. Overview
      • 11.3.22.2. Segments and Product
      • 11.3.22.3. Key Financials
      • 11.3.22.4. Market Developments
      • 11.3.22.5. Market Strategy
    • 11.3.23. Mankind Pharma
      • 11.3.23.1. Overview
      • 11.3.23.2. Segments and Product
      • 11.3.23.3. Key Financials
      • 11.3.23.4. Market Developments
      • 11.3.23.5. Market Strategy

12. Appendix

  • 12.1. Research Methodology
  • 12.2. Research Assumptions
  • 12.3. Acronyms and Abbreviations
Show more
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Contact Us +1-866-353-3335
Hi, how can we help?
Contact us!